ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

Aster DM Quality Care Earnings Call: Key Takeaways

Aster DM Healthcare reported strong Q4 FY26 performance with proforma revenue growing 18% YoY and EBITDA 25%, driven by volume growth and margin expansion ahead of its merger with Quality Care.

Highlights
Revenue growthFY26 proforma revenue grew 14% to ₹9,273 crore.
MarginsEBITDA margins expanded 116 bps to 21.7% in FY26.
Demand visibilityStrong patient volumes and 12% increase in total patient volumes.
Management confidenceHigh; citing steady growth trajectory and successful realization of merger synergies.

Growth

Combined FY26 revenue reached ₹9,273cr (+14% YoY); Operating EBITDA hit ₹2,013cr (+21% YoY) with 21.7% margins.

Outlook

Plans to add 4,445 beds (reaching 15,000+ total) with ₹2,000cr QCIL capex for 1,700 beds over 3-4 years.

Risks

Nurses' strike in Kerala and macro headwinds impacting MVT from UAE were noted as temporary headwinds.

Source

Earnings Call filed with NSE, NSE: ASTERDM. Summary written with AI assistance from the document.

Read the document ↗

Aster DM Quality Care Ltd: key numbers

Share price
₹725.10
Market cap
₹63,205 Cr
Revenue (annual)
₹4,643 Cr
Net profit (annual)
₹388.1 Cr
P/E (TTM)
134.3×Sector 54.5×
Promoter holding
53.79%+13.40% QoQ
FII holding
12.26%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Aster DM Quality Care Ltd

All →